Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 6,070.00
+290.00 (5.02%)
At close: Aug 11, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 41.39 billion as of August 11, 2026. Its market cap has increased by 8.85% in one year.
Market Cap
41.39B
Enterprise Value
30.53B
Revenue
36.27B
Ranking
n/a
PE Ratio
6.08
Stock Price
6,070.00
ChartMarket Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 41.39B, a decrease of -13.03%. That is a compound annual growth rate of -2.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 41.39B | -12.64% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 187.64B |
| JW Shinyak | 121.80B |
| CG MedTech | 108.53B |
| Sewoon Medical | 101.73B |
| OSTEONIC | 101.71B |
| SCL Science | 57.76B |
| KM Corporation | 35.98B |
| MEDYSSEY Co.,Ltd | 35.83B |